Medicare now covers GLP-1 weight-loss drugs for $50 a month
Digest more
CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
NeuroX, a neurology-focused online consultation service, and its physician network ATP Partners announced it will participate in the Centers for Medicare and Medicaid Services (CMS) GUIDE Program to enhance care for dementia patients. NeuroX, American ...
Millions of people with Medicare are now eligible to get discounted GLP-1 drugs for weight loss under a special program. Here's how it will work.
